Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4906)
All Articles published online
|
Publishing Process of This Article
|
Dec 6, 2020 (publication date) through Jul 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang RB, Li YC, Zhou Q, Lv SZ, Yuan KY, Wu JP, Zhao YJ, Song QK, Zhu B. Overexpression of CD155 is associated with PD-1 and PD-L1 expression on immune cells, rather than tumor cells in the breast cancer microenvironment. World J Clin Cases 2020; 8(23): 5935-5943 [PMID: 33344592 DOI: 10.12998/wjcc.v8.i23.5935] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i23/5935.htm |
| Number | Citing Articles |
| 1 |
Kohei Mori, Kazumasa Matsumoto, Noriyuki Amano, Dai Koguchi, Soichiro Shimura, Masahiro Hagiwara, Yuriko Shimizu, Masaomi Ikeda, Yuichi Sato, Masatsugu Iwamura. Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer. Cancers 2022; 14(6): 1576 doi: 10.3390/cancers14061576
|
| 2 |
Passant Essam Eldin Shibel, Eman Ahmed Abd Elmaogod. Immunohistochemical expression of CD155 in invasive female breast carcinoma and its correlation with tumor infiltrating natural killer cells. Beni-Suef University Journal of Basic and Applied Sciences 2023; 12(1) doi: 10.1186/s43088-023-00370-z
|
| 3 |
Fenling Zhou, Lu Chen, Peng Lu, Yuli Cao, Cuilan Deng, Gexiu Liu. An integrative bioinformatics investigation and experimental validation of chromobox family in diffuse large B-cell lymphoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11108-6
|
| 4 |
Hana Triki, Ken Declerck, Slim Charfi, Wala Ben Kridis, Kais Chaabane, Sawssan Ben Halima, Tahya Sellami, Ahmed Rebai, Wim Vanden Berghe, Boutheina Cherif. Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia. Cancer Immunology, Immunotherapy 2022; 71(5): 1139 doi: 10.1007/s00262-021-03064-6
|
| 5 |
Florence Boissière-Michot, Marie-Christine Chateau, Simon Thézenas, Séverine Guiu, Angélique Bobrie, William Jacot. Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1058424
|